Periodic Reporting for period 1 - INSPIRE (INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.)

New drug candidates often have off-target effects resulting in adverse events, thus representing a major limitation for drug R&D. Safety pharmacology aims to detect, understand and reduce undesirable pharmacodynamic effects early-on. Especially, cardiovascular toxicity is...